Search results
PROMOTED
Rhythm Interventions Online is back! Mark your calendars for Thursday 20 and Friday 21 November, as we bring you the most dynamic and immersive virtual experience in electrophysiology and cardiac rhythm management.
After five hugely successful editions, RIO has cemented its place as a must-attend global event, delivering world-class education to thousands of healthcare professionals worldwide.
…
View more
RIO 2025 - Day One | Global
Start date:
Nov 20, 2025
Broadcast
Added:
11 months ago
In this exclusive episode of the "Innovations in Cardiology" podcast series, host Dr Dipti Itchhaporia, past president of the American College of Cardiology, delves into the latest advancements in cardiovascular health. She is joined by Dr Valentin Fuster, a pioneer in the field, who shares invaluable insights into the impact of biological ageing, the connection between the heart and brain, and…
View more
Added:
2 months ago
Start date:
May 06, 2025
Join Dr Luca Santini (Rome, IT) and Prof Klaus Witte (Leeds, UK) for an engaging educational webinar exploring the critical importance of sensitivity and specificity in Insertable Cardiac Monitors (ICMs).Discover how reducing false positives impacts sensitivity, why balancing these factors is essential, and what real-world data reveals about achieving clinical accuracy. The session will also…
View more
Added:
5 months ago
Added:
7 months ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9…
View more
Added:
11 months ago
Added:
2 months ago
Source:
Arrhythmia Academy
Managing antithrombotic therapy in older patients with both atrial fibrillation (AF) and stable coronary artery disease (CAD) presents a clinical challenge, balancing the risks of thrombotic events and bleeding. A new post hoc analysis of the AFIRE trial sought to clarify whether the effects of rivaroxaban monotherapy differ across age groups compared to combination therapy with an antiplatelet…
View more
Added:
3 months ago
Source:
Radcliffe Cardiology
AUTHOR: Liam ONeillDespite a stable overall incidence over two decades, outcomes for out-of-hospital cardiac arrest (OHCA) have significantly improved, according to a large retrospective cohort study from the US. The findings reveal that while the total number of OHCAs has not changed, the patterns of incidence differ markedly across age groups and presenting cardiac rhythms, with survival…
View more
Added:
1 month ago
Source:
Arrhythmia Academy
A strategy of actively increasing plasma potassium to high-normal levels significantly lowered the risk of arrhythmia events in high-risk patients with an implantable cardioverter–defibrillator (ICD), according to results from the POTCAST trial.¹˒² The findings were presented at the European Society of Cardiology (ESC) Congress 2025 and simultaneously published in the New England Journal of…
View more